APROVEL 300MG 28TABS
كود الصنف: 36593
8.840 د.ك
treat hypertension
Out of stock
Notify me when item is back in stock.
Aprovel belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced in the body which binds to receptors in blood vessels causing them to tighten. This results in an increase in blood pressure. Aprovel prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax and the blood pressure to lower.
Based on 0 reviews
| 0% | ||
| 0% | ||
| 0% | ||
| 0% | ||
| 0% |
Only logged in customers who have purchased this product may leave a review.
- VICHY CAPITAL SOLEIL VELVETY CREAM 50+ 50ML
11.850 د.كOriginal price was: 11.850 د.ك.8.295 د.كCurrent price is: 8.295 د.ك. - ULTRA URI MAX UTI FORTE 60 TABLET 6.500 د.ك
- CLARITINE SYRUP 100ML 2.000 د.ك
- LIERAC PHYTOLASTIL SOLUTION STRECHMARK 11.250 د.ك
Related Products
used mainly to control blood glucose level for type 2 diabetic pateints
Out of stock
used mainly to control blood glucose level for type 2 diabetic pateints
Out of stock
used to treat essential hypertension ,
especially for patients whose blood pressure cannot be controlled with monotherapy
مدر للبول (حبوب الماء). يستخدم بشكل رئيسي في علاج قصور القلب وارتفاع ضغط الدم. يقلل من التورم .
treat high blood pressure (hypertension) in adult patients and in children and adolescents aged 6 to <18 years, treat adult heart failure patients with reduced heart muscle function
used mainly to control blood glucose level for type 2 diabetic pateints
54 in stock
used mainly to control blood glucose level for type 2 diabetic pateints
81 in stock
oral hypoglycemic drug used to control blood glucose level for type 2 diabetic pateints
Out of stock
used to treat essential hypertension ,
especially for patients whose blood pressure cannot be controlled with monotherapy
used to treat essential hypertension ,
especially for patients whose blood pressure cannot be controlled with monotherapy

















Reviews
There are no reviews yet.